|
FDA expands indication of BI inhaler to include maintenance treatment of asthma
FierceDrugDelivery The only inhaler that administers a slow-moving mist to help respiratory patients inhale the medication is now FDA-approved for the long-term maintenance treatment of asthma, in addition to its previous indication to treat COPD. The expanded indication … FDA Approves New Indication for Boehringer's Spiriva Respimat Landmark year for Boehringer Ingelheim's respiratory portfolio – new data for … ERS 2015: Landmark year for Boehringer Ingelheim's respiratory portfolio – new … |
View full post on asthma – Google News